It was revealed that cells with high LIM scores were predominantly fibroblasts, and Erlotinib, fulvestrant, EPZ5676, and AZD1208 were identified as potential therapeutic agents for patients in the low-LIMRS group, whereas vinblastine, docetaxel, paclitaxel, and vinorelbine may be more suitable for high-LIMRS group pati...
Xin-Yu Zhao, Yili Shao, Huang Huang et al.· Translational Oncology· 0 citations
In vitro results of this study show that FGFR2 mediates HIF-1α and affects CRC cell proliferation, migration and invasion, which is consistent with the results of bioinformatics analysis.
Yi-Yang Hu, Liu-Xu Yao, Yuhong Li et al.· Tissue & Cell· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.